Methyl 3-(4-methylbenzenesulfonamido)benzoate

Catalog No. :
ACGSVH069
CAS No. :
173436-66-3
Molecular Formula :
C15H15NO4S
Molecular Weight :
305.36

IUPAC Name:methyl 3-((4-methylphenyl)sulfonamido)benzoate

Methyl 3-(4-methylbenzenesulfonamido)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$80.00Login to see priceIn stockIn stock
1g98%$214.00Login to see priceIn stockIn stock
5g98%$623.00Login to see priceIn stockInquiry
25g98%$2342.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(4-methylbenzenesulfonamido)benzoate
IUPAC Namemethyl 3-((4-methylphenyl)sulfonamido)benzoate
MDL No.MFCD00994918
Molecular FormulaC15H15NO4S
Molecular Weight305.36
SMILESO=C(OC)C1=CC=CC(NS(=O)(C2=CC=C(C)C=C2)=O)=C1
InChI KeyCVKBYFCJQSPBOI-UHFFFAOYSA-N
Synonymmethyl 3-(4-methylphenylsulfonamido)benzoate;MSAB;Methyl 3-(4-Methylbenzenesulfonamido)benzoate;GSK549;Benzoic acid, 3-[[(4-methylphenyl)sulfonyl]amino]-, methyl ester;MSAB >=95% (HPLC);anti-tumor,Wnt,inhibit,MSAB,degradation,β-catenin,Inhibitor,Beta catenin,cancer;3-Methoxycarbonylphenyl toluenesulfonamide
CAS No.173436-66-3
PubChem CID1159052

Synthetic Route by SureRoute

1. ACGSVH069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMEFU063 route compound structure diagram
    ACMEFU0634518-10-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGSVH069 route product structure diagram
    ACGSVH069173436-66-3 In Stock
Inquiry

2. ACGSVH069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMEFU063 route compound structure diagram
    ACMEFU0634518-10-9 In Stock
  2. Plus
  3. ACAELZ742 route compound structure diagram
    ACAELZ7427403-46-5 In Stock
  4. Then
  5. ACGSVH069 route product structure diagram
    ACGSVH069173436-66-3 In Stock
Inquiry

Comments (0)